Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 533.50
   
  • Change Today:
    $-19.65
  • 52 Week High: $567.23
  • 52 Week Low: $409.47
  • Currency: US Dollars
  • Shares Issued: 235.99m
  • Volume: 1,702,816
  • Market Cap: $125,901m
  • RiskGrade: 164
  • Beta: 0.01

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 533.50
Change Today $ -19.65
% Change -3.55 %
52 Week High $567.23
52 Week Low $409.47
Volume 1,702,816
Shares Issued 235.99m
Market Cap $125,901m
Beta 0.01
RiskGrade 164

What The Brokers Say

Strong Buy 8
Buy 14
Neutral 5
Sell 0
Strong Sell 1
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 03-Nov-2026

Time Volume / Share Price
15:16 40 @ $533.50
15:16 40 @ $533.51
15:16 40 @ $533.52
15:16 40 @ $533.52
15:16 40 @ $533.51

Top of Page